Rainbow Children's Medicare Ltd
Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities.[2]
- Market Cap ₹ 13,665 Cr.
- Current Price ₹ 1,348
- High / Low ₹ 1,649 / 878
- Stock P/E 62.1
- Book Value ₹ 115
- Dividend Yield 0.22 %
- ROCE 23.7 %
- ROE 24.4 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 42.0% CAGR over last 5 years
Cons
- Stock is trading at 11.7 times its book value
- Working capital days have increased from 30.0 days to 82.8 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|
148 | 234 | 402 | 543 | 695 | 614 | 925 | 1,114 | 1,214 | |
110 | 204 | 332 | 430 | 486 | 449 | 626 | 729 | 805 | |
Operating Profit | 39 | 30 | 70 | 112 | 209 | 166 | 299 | 385 | 408 |
OPM % | 26% | 13% | 17% | 21% | 30% | 27% | 32% | 35% | 34% |
10 | 16 | 10 | 8 | 12 | 12 | 21 | 27 | 33 | |
Interest | 2 | 3 | 4 | 6 | 46 | 44 | 53 | 55 | 53 |
Depreciation | 7 | 18 | 28 | 36 | 65 | 68 | 77 | 84 | 96 |
Profit before tax | 40 | 24 | 47 | 79 | 109 | 66 | 190 | 273 | 292 |
Tax % | 33% | 28% | 22% | 25% | 35% | 25% | 25% | 25% | |
27 | 17 | 36 | 60 | 71 | 49 | 142 | 206 | 220 | |
EPS in Rs | 28.65 | 18.39 | 8.30 | 13.56 | 16.12 | 11.24 | 15.13 | 20.28 | 21.67 |
Dividend Payout % | 7% | 11% | 12% | 7% | 12% | 0% | 13% | 15% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 23% |
3 Years: | 17% |
TTM: | 20% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 42% |
3 Years: | 43% |
TTM: | 31% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 47% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 20% |
3 Years: | 22% |
Last Year: | 24% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 9 | 9 | 44 | 44 | 44 | 44 | 94 | 102 | 102 |
Reserves | 170 | 272 | 304 | 359 | 371 | 421 | 531 | 987 | 1,066 |
Preference Capital | 6 | 11 | 11 | 11 | 11 | 11 | 11 | 0 | |
6 | 13 | 13 | 50 | 469 | 484 | 548 | 538 | 600 | |
36 | 51 | 84 | 102 | 128 | 120 | 112 | 132 | 111 | |
Total Liabilities | 221 | 346 | 445 | 555 | 1,012 | 1,070 | 1,285 | 1,759 | 1,878 |
54 | 123 | 293 | 333 | 663 | 722 | 813 | 891 | 940 | |
CWIP | 30 | 28 | 12 | 21 | 43 | 29 | 6 | 23 | 69 |
Investments | 24 | 2 | 0 | 5 | 24 | 37 | 42 | 105 | 192 |
113 | 193 | 140 | 197 | 282 | 282 | 424 | 740 | 677 | |
Total Assets | 221 | 346 | 445 | 555 | 1,012 | 1,070 | 1,285 | 1,759 | 1,878 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|
23 | 17 | 48 | 96 | 178 | 142 | 214 | 315 | |
-21 | -107 | -42 | -125 | -123 | -87 | -169 | -460 | |
-4 | 92 | -7 | 31 | -54 | -56 | -41 | 148 | |
Net Cash Flow | -1 | 2 | -2 | 2 | 1 | -2 | 4 | 2 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 11 | 10 | 14 | 19 | 19 | 27 | 16 | 19 |
Inventory Days | 39 | 35 | 36 | 32 | 52 | 35 | 27 | 43 |
Days Payable | 130 | 107 | 148 | 153 | 152 | 190 | 115 | 195 |
Cash Conversion Cycle | -80 | -62 | -97 | -102 | -80 | -128 | -72 | -133 |
Working Capital Days | -16 | -30 | -28 | -5 | 9 | 12 | -5 | 83 |
ROCE % | 7% | 20% | 23% | 12% | 23% | 24% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
13 May - Invite of the Earnings Conference Call for Investors/ Analysts to be held on Tuesday, May 21, 2024 at 10:00 AM (IST) to discuss the financial …
- Board Meeting Intimation for Approval Of Audited (Standalone & Consolidated) Financial Results For The Period Ended March 31, 2024 And To Consider Recommending Final Dividend, If Any. 12 May
-
Certificate Under Regulation 40(9) & 40(10) Of SEBI (LODR) Regulations, 2015
20 Apr - Certificate issued by M/s. PI & Associates, Company Secretaries for the Financial Year ended March 31, 2024
-
Compliance Certificate For The Year Ended March 31, 2024
10 Apr - Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the year ended March 31, 2024
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 3 Apr
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022TranscriptPPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
Jun 2022Transcript PPT
Infrastructure:
As of FY23, RCML operates 16 hospitals and 3 clinics operating in 6 cities in India. It has a capacity of 1650+ beds and 730+ doctors.[1] A number of doctors are trained and possess qualifications from the UK, USA, Canada, Australia.[2]